chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced a flushed feeling just underneath the skin on my thighs and arms starting a few hours after the shot. At some point, that included numbness and tingling in the lower arms and hands. The sensations would come and go randomly, and after about a week, the flush waves would stop, but I would continue to have the numbness and tingling intermittently. I noticed it was more prominent in the ring and pinky fingers. It lasted up until the second shot and so I contacted a doctor through my insurance via a telehealth visit and they told me it was safe to do the 2nd shot and was likely related to a vitamin deficiency or something unrelated.
Started developing a bloody nose; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer (patient himself) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration on 16Mar2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 17Mar2021, the patient experienced, when he was exercising, he started developing a bloody nose. The outcome of event was unknown.  No follow up attempts are possible; information about Lot/batch number cannot be obtained.
No adverse event reported, however this vaccine was administered in error before the 2 month recommended time between the two injections.
This is a spontaneous report from a non-contactable pharmacist.   A female patient of an unspecified age received a single dose of  PREVNAR 13 on an unknown date for immunization. The patient medical history and concomitant medications were not reported. On an unknown date the patient experienced rash on the body, fever and ache, which were described as follows:  a day after vaccination, the patient got fever and ache and a week later, she developed some rash (not into face or arm or leg) for about 4 days. Pharmacist didn't think that the rash was due to pneumococcal 13-val conj vaccination, because it appeared a week later. The final outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.
Case number PHEH2014US025045, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 90-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 31 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Patient's mother asked us if we could give Pediatric Pfizer to her son. I asked how old he was, and she stated "5". I gave her a consent form to fill out, and for the "Age", she put "5". We gave the pediatric Pfizer, and when it came time to upload to website, we noticed that the son was only 4 years and 7 months old. When I asked the mother again, how old her son was, she stated again that he was "5". When I questioned her regarding the discrepancy with his birthday, she stated that "she considers him to be 5 years old" but admitted he will actually turn 5 in a few months. She apologized multiple times for misleading us.
I had a strong immune reaction to the 2nd moderna shot with fevers of 102.6, chills, severe body aches, bad headache , severe left arm pain, andHR 120- 130's. I had an exacerbation of my right lower leg CRPS and the right arm CRPS after the shot and the day after the shot on 2/3 /21 I noticed for the first time the first signs and symptoms of Raynaud's on the right index finger. The Raynaud's symptoms started getting progressively worse extending to all fingers and toes and I started getting daily symptoms with multiple episodes per day associated with any changes in temperature or stress. The fever, chill, severe headache , and severe arm pain resolved after 48 hrs ,but  I also started having generalized muscle pains and generalized extremity edema. The CRPS spread from the right lower leg and right arm to the right thigh , right ankle, right foot, left thigh, left ankle, left foot and left arm. I also started having weakness in the left hand and the weakness of the right hand the I previously had, got worse.  After the first moderna shot , I only had mild left arm pain.
01June07 seen in ER for severe reaction to smallpox including blisters and swelling. Given erythromycin and Ibuprofen, follow up at the Clinic on 04June07 with improvement noted to site.
Got the vaccine around 1600 on Thursday, November 18th. Woke up in the middle of the night with my arm on fire and painful. On Friday, around 1200 I started getting chills. My temp was normal, but I couldn't get warm or stay warm. I was fatigued and nauseous. I took ibuprofen (~500mg) around 1400. I started feeling better around 1800 that night. I had a hard time sleeping as my arm was still hurting and it was hot, swollen and sensitive to the touch at the injection site. On Sunday, I noticed the my arm was still swollen, sensitive to touch, itchy and hot. When I looked I noticed I had 2 red rashes (one about the size of a quarter, the other about 2" long and about 1" wide). I took pictures and had made marks to identify if it spreads. On Monday, 22 November, the rash has spread outside of the marks from the previous day. My arm is still swollen, itchy, hot and hurts to touch and move sometimes.
This spontaneous report was received from a pharmacist via a company representative refers to a 68 year old female patient. The patient's pertinent medical history, drug reaction/allergies and concomitant medications were unknown. On an unknown date, she was vaccinated with ZOSTAVAX. On an unknown date, she experienced injection site swelling and redness for 4 to 7 days. She recovered from the events on an unknown date. The reporter did not provide the relatedness of the events with ZOSTAVAX. Additional information is not expected as the reporter did not wish to be contacted.
Information has been received from a registered nurse concerning a 79 year old female oncology patient, who on Dec 21 2004 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). On Dec 2004, the patient experienced pain, redness and swelling from the injection site to the elbow. The patient was treated with antibiotics, The patients outcome was unknown. Unspecified medical attention was sought. No product quality complaint was involved. The nurse would like a lot check for lot 0692P. It was also reported that tow other patients were vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 649988/0692P) and experienced adverse events (WAES0412USA02891, WAES0501USA00660). The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory, The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
Evening after receiving vaccine, noticed burring and itching of skin.  Worsened daily to include rash on arms, face, stomach, legs and back.  Sought treatment from family doctor 8 days after vaccination.  Treated with oral corticosteroids and diphenhydramine.  Rash resolved.
Pt reports pain from the top of her rt shoulder down the arm and is unable to move her arm and when she does, it is very painful and difficult to move. Shot location doesn't look swollen or red but is painful to the touch.
PATIENT GIVEN THE PFIZER COVID 19 BIVALENT AS AN INITIAL DOSE. PATIENTS FATHER BROUGHT HER IN FOR HER COVID SHOT. THE PHARMACY TECH AT DATA ENTRY AND IMPUT ENTERED THE BIVALENT VACCINE. UPON PREPARING THE COMPUTER TO ADMINISTER AND VERIFY THE VACCINE (WHICH SHOWED THE BIVALENTY DOSE) I  HAD VERIFIED THE BIVALENT DOSE AND ADMINISTERED IT. AFTERWARDS, THE FATHER EXPLAINED IT AS HER FIRST DOSE.
HEART ATTACK; This spontaneous report received from a patient concerned a 65 year old female. The patient's weight was 88 pounds, and height was 62 inches. The patient's past medical history included: stroke (at 34 age-hereditary) from that patient was healthy since, concurrent conditions included: very little smoker, abstain from alcohol, and other pre-existing medical conditions included: The patient had no drug abuse or illicit drug usage. The patient experienced drug allergy when treated with Plavix (clopidogrel bisulfate). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: unknown) dose was not reported, 1 total, administered on 20-MAY-2021 at left arm for prophylactic vaccination. Concomitant medications included Brilinta (ticagrelor) for unknown indication.  On 28-JUN-2021, the patient experienced heart attack, tightness in shoulder blade and could not get comfortable. On 29-JUN-2021 patient was hospitalized and discharge on 02-JUL-2021. On an unspecified date, in hospital ran a thing up to check the heart through the groin (test name unspecified) and blood test (result was unknown) was done. Treatment medications included: Coumadin (warfarin sodium), Baby aspirin (acetylsalicylic acid), atorvastatin, and metoprolol. She was on Brilinta (ticagrelor) but she was taken off on 12-AUG-2021 and put on the warfarin because she had a sonogram done which showed a blockage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of heart attack was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20210829122-JANSSEN COVID-19 VACCINE Ad26.COV2.S -  heart attack-This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
On 6/14/99, the pt developed chickenpox with a high fever of 105 and a rash with 40-50 spots.
My son lost all of his speech at around 18 months and started to withdraw from social interactions with everyone except me, his mother. By 27/28 months, he was diagnosed PDD NOS (pervasive developmental delay). He was developing normally prior to MMR. On annual report received 04/22/2003, mother states, "I have contracted a law firm to follow up with the vaccine caused damage done to my son".
inadvertent administration of a first dose of Moderna vaccine to a patient age 12 through 17 years
8/7/02 dad called to report child developed hives, itching morning after vaccines were given. He took him to see MD that report accompanies this report.
Chills; didn't feel like himself; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and FEELING ABNORMAL (didn't feel like himself) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.  No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced CHILLS (chills) and FEELING ABNORMAL (didn't feel like himself). At the time of the report, CHILLS (chills) and FEELING ABNORMAL (didn't feel like himself) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Medications were not provided by the reporter. Treatment Information was not provided by the reporter.
Pain at injection site and eventually within the next 24 hrs also present in right shoulder joint.  Off and on pain in R shoulder joint since the day of injection.  Seen in office for assessment due to ongoing issues with pain on 7/25/22 as mom stated pain hadn't resolved fully and patient was still complaining especially at night time.  Was seen to have full use/no limitations of arm by history and on exam with mild pain reported on external rotation of arm at shoulder joint to 90 degrees with arm abducted.  No issues with fever, swelling, bruising, rashes at injection site.  No weakness with arm, no numbness or tingling of that affected extremity.  Advised by history indicative of a bursitis within shoulder joint and recommended supportive care with NSAID therapy OTC at an anti-inflammatory dosing regimen x 3 days along with rest out of sports/overuse of affected arm over the following week.  Advised if no improvement in 1 week's time that orthopedic evaluation would be best next step.
The arm they received the injection site became very painful and I had a limited mobility in it for two days. I ran a temperature starting a few hours after having the shot and developed blisters on my lips from the fever. I also felt nauseous and weak. It was impossible to sleep for two nights due to the pain. This morning 10/19/18, while taking a shower I got very nauseous and dizzy and ended up falling in the shower hitting my head lower back and entering my ankle. I was in the ER for five hours. In the ER they looked at the red skin from my pneumonia shot and think it might be cellulitis. I have never felt so sick in my life after having a vaccine.
Suspected Vaccination failure; HCP confirmed Shingles / Developed shingles; Red spot on his right back / spread under his right armpit to his stomach; The redness has formed blisters on his stomach area; Spot gave him a burning sensation; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 10th November 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, the patient received the 1st dose of Shingrix. On 23rd July 2021, 621 days after receiving Shingrix, unknown after receiving Shingrix and an unknown time after starting Valtrex, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, red rash, blister and burning sensation. The patient was treated with valaciclovir hydrochloride (Valtrex) and analgesic, nos (Pain Medication). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, red rash, blister and burning sensation were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, red rash, blister and burning sensation to be related to Shingrix and Shingrix.  Additional details were provided as follows: The case was reported by the patient himself. The patient received the two doses of Shingrix and patient had shingles. The patient stated that on last friday before reporting date he noticed a red spot on his right back about the size of a silver dollar,the patient was working in yard so he thought he was bitten by an insect. On 25th July 2021,the red spot grew to the size of a basketball and spread under his right armpit to his stomach. The patient went to the HCP and the HCP confirmed it as Shingles. At the day of reporting the redness had formed blisters on his stomach area. The HCP started on patient valtrex and pain medications for treatment. The reporter stated that he developed shingles even though he received both doses of the Shingrix. The reporter did not consent to follow up. The reporter did not give permission to contact HCP. This case was considered as suspected vaccination failure since the details regarding laboratory test confirming shingles were unknown at the time of reporting.
This spontaneous report was received from a certified medical assistant referring to a currently 3 year old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date, the patient was vaccinated with an improperly stored dose of VAQTA, lot number N017094 and expiration date of 31-AUG-2018 for prophylaxis (dose and route of administration were not provided). The vaccine was exposed to a temperature excursion of 47.1°F with a time frame of 30 minutes. There was no previous temperature excursion. A "data logger" was involved. No adverse effects were reported. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1710USA006357: US-009507513-1710USA006358: US-009507513-1710USA006359: US-009507513-1710USA006360: US-009507513-1710USA006361: US-009507513-1710USA006362: US-009507513-1710USA006373: US-009507513-1710USA006364: US-009507513-1710USA006365: US-009507513-1710USA006366: US-009507513-1710USA006367: US-009507513-1710USA006368: US-009507513-1710USA006369: US-009507513-1710USA006370: US-009507513-1709USA011980: US-009507513-1710USA006372: US-009507513-1710USA006356: US-009507513-1710USA006355: US-009507513-1710USA006363:
This spontaneous report was received from a physician via company representative and refers to a 5 months old patient of unknown gender. Patient's medical history, concurrent conditions and concomitant medication were not reported. In approximately April 2016 (reported as about a month ago), the patient was vaccinated with a dose of PNEUMOVAX 23, intramuscular or subcutaneous (strength, dose and frequency not reported) (Inappropriate schedule of drug administration) instead of PREVNAR (wrong drug administered). The patient did not seek medical attention and no treatment was given. No lab studies were performed. At the time of this report, the patient's status was unknown, because the reporting physician did not hear anything. No further information provided. Additional information has been requested.
Client given saline instead of COVID-19 Pfizer vaccine. Client re-vaccinated 4/24/2021 at 14:30. Client given ER8735 IM in right deltoid. Expiration 7/31/2021.
Active duty service member who experienced a temporally related event of left eye uveitis with onset day 9 afer dose #2 and day 29 after dose #1 of Pfizer BioNTech.
Got the vaccine 3 months later got shingles/ Suspected vaccination failure; Shingles, right arm Lasted 1 month; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she got the Shingles vaccine 3 months later got shingles in right arm lasted 1 month. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. This case has been linked to the case US2021AMR233762 reported by the same reporter for 1st outbreak.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR233762:1st outbreak
The patients grandma (guardian) called our office and scheduled the patient and his older sibling for Covid-19 vaccines during one of our after hours clinics. I confirmed the patients name and date of birth before giving him the vaccine but didn't realize that he wasn't 5 years old yet. He was only 4 years and 8 months old at the time of the vaccine. The patient did not have an adverse reaction to the Covid-19 vaccine.
Have A Fib; This spontaneous case was reported by a pharmacist and describes the occurrence of ATRIAL FIBRILLATION (Have A Fib) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced ATRIAL FIBRILLATION (Have A Fib). At the time of the report, ATRIAL FIBRILLATION (Have A Fib) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were given. No treatment information were provided.  Case narrative: I want to know if I need the booster because it has not been 6 months but I have A Fib A.  Company comment: This is a spontaneos case concerning a patient of an unknown age and gender who wants to know if she/he needs the booster because it has not been 6 months but she/he have A Fib. It is not clear if atrial fibrillation was reported as an adverse event or if the patient refers to a concurrent medical condition for which she/he would have an indication of a booster dose. Further information has been requested. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a patient of an unknown age and gender who wants to know if she/he needs the booster because it has not been 6 months but she/he have A Fib. It is not clear if atrial fibrillation was reported as an adverse event or if the patient refers to a concurrent medical condition for which she/he would have an indication of a booster dose. Further information has been requested. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Arm hurts, can't lift arm above shoulders or push open door with that arm. Dr diagnosed inflammation of the muscle. Is taking Ibu 600 qid.
Syncopal type feeling.  Nausea feeling and unsteady on his feet.  Light headed when he was standing up.
Headache, Fever, NauseaVomiting, BODY ACHES, SORE ARM, FATIGUE, CHILLS, HOT FLASHES,  ABDOMINAL CRAMPING Narrative:  EMPLOYEE STATES EXPERIENCED SIMILAR SIDE EFFECTS TO FIRST AND SECOND VACCINE. ALSO STATES SHE WAS POSITIVE FOR COVIS AND CLEARED FROM QUARENTINE ON 1/8/21 (4 DAYS PRIOR TO FIRST DOSE) SHE IS ALSO 4 MONTHS POST-PARTUM AND CURRENTLY NURSING (BREAST FEEDING).
Red patches or bumps on the skin all over body.  Contacted pt on 6Feb03, pt states seeing Derm for problem and has more bumps, but not as red.
Fever 105(R) 2 days after immunization.  Required ER visit.
Breakthrough case admission after 3 vaccines Moderna 3/1/21 023M20A;  Moderna 3/29/21 Lot# 018B21A;  Moderna 11/22/22 Lot# 062F22A
First dose was over 4 months ago; Symptoms similar to COVID; This spontaneous case was reported by a non-health professional and describes the occurrence of SUSPECTED COVID-19 (Symptoms similar to COVID) and PRODUCT DOSE OMISSION ISSUE (First dose was over 4 months ago) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in January 2021.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced SUSPECTED COVID-19 (Symptoms similar to COVID). On 30-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (First dose was over 4 months ago). On 01-Apr-2021, SUSPECTED COVID-19 (Symptoms similar to COVID) had resolved. On 30-Jul-2021, PRODUCT DOSE OMISSION ISSUE (First dose was over 4 months ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.